Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

7.950
+0.2903.79%
Volume:156.67M
Turnover:1.24B
Market Cap:91.60B
PE:19.69
High:8.040
Open:7.750
Low:7.690
Close:7.660
52wk High:11.454
52wk Low:4.152
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:1.84
T/O Rate:1.36%
Dividend:0.25
Dividend Rate:3.10%
EPS(LYR):0.404
ROE:10.83%
ROA:5.65%
PB:2.52
PE(LYR):19.69
PS:3.22

Loading ...

CSPC Pharmaceutical Group Stock Rallies 3.8% in Hong Kong

Dow Jones
·
Yesterday

CSPC PHARMA (01093): Marketing Application for Pertuzumab Injection Accepted by China's NMPA

Stock News
·
Nov 12

CSPC Pharmaceutical Group Pertuzumab Injection Marketing Application Accepted by NMPA

Reuters
·
Nov 12

CSPC Pharmaceutical - Nmpa Accepts Marketing Authorisation for Pertuzumab Injection

THOMSON REUTERS
·
Nov 12

CSPC Pharma's HER2 Antibody Application Accepted, CR Sanjiu Secures Rare Disease Drug, Domestic CAR-T Goes Global for Over $860M

Deep News
·
Nov 11

CSPC Pharmaceutical Group Limited (1093) Announces Date of Board Meeting for Third Quarter Results

Bulletin Express
·
Nov 10

CSPC Pharmaceutical Group Board to Approve Third Quarter Results

Reuters
·
Nov 10

CSPC Pharmaceutical Group Stock Rises 2.7% in Hong Kong, Outperforms Competitors

Dow Jones
·
Nov 10

CSPC Pharmaceutical Group Stock Slides 2.3% in Hong Kong

Dow Jones
·
Nov 07

Behind CSPC PHARMA's Insider Trading Scandal: Governance Risks and Performance Pressures

Deep News
·
Nov 06

BRIEF-CSPC Pharmaceutical Says Pan Weidong Resigns As Executive Director

Reuters
·
Nov 04

CSPC (1093) Announces Updated Board Composition and Committee Assignments

Bulletin Express
·
Nov 04

CSPC Pharmaceutical Group Files Director List with HKEX

Reuters
·
Nov 04

CSPC Pharmaceutical Group Appoints Dr. Li Chunlei as Authorised Representative

Reuters
·
Nov 04

CSPC PHARMA (01093): Dr. Li Chunlei Appointed as Authorized Representative

Stock News
·
Nov 04

CSPC Pharmaceutical - Pan Weidong Resigns as Executive Director

THOMSON REUTERS
·
Nov 04

Madrigal Pharma Q3 revenue rises on Rezdiffra demand

Reuters
·
Nov 04

CSPC PHARMA Executive Director Fined RMB5 Million by CSRC, Retains Right to Appeal

Deep News
·
Nov 04

CSPC Pharmaceutical Group Stock Slips 4.4% in Hong Kong, Underperforms Competitors

Dow Jones
·
Nov 04

CSPC (01093) Announces Unchanged Issued Shares in October 2025

Bulletin Express
·
Nov 03